5 results
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
and Treating HHV ... in HIV-AIDS Preventing ... and uncontrolled HIV ... #IDSA #Prevention ... #Treatment #management
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
HIV-AIDS Oropharyngeal ... #IDSA #Prevention ... #Treatment #management ... #opportunistic ... #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
for Treating Mycobacterium ... HIV-AIDS Treating ... for HIV-related ... #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Treating Treponema pallidum Infections (Syphilis) to Prevent Disease in HIV-AIDS
Early Stage (Primary, Secondary,
pallidum Infections ... in HIV-AIDS Early ... #IDSA #Prevention ... #Treatment #management ... #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
Complex in HIV-AIDS ... #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology